AIM ImmunoTech, Inc. (AIM)
1.35
+0.56
(+70.89%)
USD |
NYAM |
Feb 13, 15:51
AIM ImmunoTech Cash from Investing (Quarterly) : 0.296M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 201.61M |
| Agenus, Inc. | 0.076M |
| Curis, Inc. | 0.00 |
| LadRx Corp. | 0.00 |
| Plus Therapeutics, Inc. | 1.297M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.079M |
| Cash from Financing (Quarterly) | 6.654M |
| Free Cash Flow | -13.33M |
| Free Cash Flow Per Share (Quarterly) | -2.424 |
| Free Cash Flow to Equity (Quarterly) | -4.612M |
| Free Cash Flow to Firm (Quarterly) | -4.931M |
| Free Cash Flow Yield | -53.51% |